S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

EVOK Evoke Pharma Inc

0.47

-0.0155 (-3.19%)

After Hours

Last Updated: 06:05:32

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

Evoke Pharma (NASDAQ:EVOK)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Evoke Pharma Charts.

Evoke Pharma (NASDAQ:EVOK)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Evoke Pharma Charts.

Evoke Pharma Inc News

Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
Wednesday 17 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer
Friday 22 March 2024 (2 months ago) • GlobeNewswire Inc.

Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
Friday 15 March 2024 (2 months ago) • GlobeNewswire Inc.

Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
Friday 8 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Saturday 24 February 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Wednesday 21 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Evoke Pharma Announces Closing of $7.5 Million Public Offering
Wednesday 14 February 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Saturday 10 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 424B4 - Prospectus [Rule 424(b)(4)]
Saturday 10 February 2024 (3 months ago) • Edgar (US Regulatory)

Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
Friday 9 February 2024 (3 months ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Friday 9 February 2024 (3 months ago) • Edgar (US Regulatory)

More Evoke Pharma Inc News Articles

Australian SE All Ordina...

JP Morgan Chase

Invesco QQQ Trust Series 1

Commonwealth Bank Of Aus...

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions